Austedo XR Shows Symptom Improvement for Patients | Teva
Sep 20, 2025 · Patients taking Austedo XR report symptom improvement and better quality of life in real-world settings.
Patients Taking AUSTEDO XR® (deutetrabenazine) extended …
Sep 20, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia …
Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.
Phase 4 Data Support Effectiveness of Deutetrabenazine in …
Nov 26, 2025 · REFERENCES 1. AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with …
Teva Real-World Study Finds AUSTEDO and AUSTEDO XR …
Nov 10, 2025 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia …
Real-World Data Show AUSTEDO XR Delivers High Patient …
- Over 94% of 209 tardive dyskinesia patients surveyed reported movement improvement when treated with AUSTEDO XR (deutetrabenazine) extended-release tablets. - Patients …
Teva’s AUSTEDO and AUSTEDO XR demonstrate real-world improvement …
Nov 11, 2025 · The results, presented at the 2025 Neuroscience Education Institute Fall Congress in Colorado Springs, Colorado, demonstrated that treatment with AUSTEDO or …
Deutetrabenazine Improved Tardive Dyskinesia Symptoms
Sep 17, 2025 · These survey results highlight the positive patient experiences reported with the use of Austedo XR, demonstrating that as a result of diminished motor symptoms, patients …
Patients Taking AUSTEDO XR® (deutetrabenazine) extended
Sep 22, 2025 · These survey results highlight the positive patient experience with AUSTEDO XR, demonstrating that, as a result of reduced motor symptoms, patients living with TD …
94% Movement Improvement: Teva's AUSTEDO XR Transforms Life …
Sep 21, 2025 · 209 tardive dyskinesia patients report 94% movement improvement and 89% satisfaction with AUSTEDO XR in real-world survey. 96% plan to continue treatment, citing …